Home/Hedge Fund Intelligence/CytomX Therapeutics, Inc.
Nasdaq: CTMXStockForm 13F30 Jun 2026

Hedge funds that hold CytomX Therapeutics, Inc. Nasdaq: CTMX

CUSIP 23284F105 · who reports it, how much, and how much it matters to them

27 of the 720 hedge fund managers we track reported shares of CytomX Therapeutics, Inc. (Nasdaq: CTMX) on Form 13F for 30 June 2026. Between them they reported USD 246m. The largest position belongs to Kynam Capital Management, at USD 81m.

Managers reporting it27of 720 we track
Value they reportUSD 246mshares only, 30 Jun 2026
Funds they run278with a file on PPLI.com
Largest positionUSD 81mKynam Capital Management
Typical weight0.0%median share of a manager's book
Heaviest weight4.5%Kynam Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

27 managers, USD 246m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports CytomX Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1Kynam Capital Management1 fund on PPLI.comUSD 81m4.5%
2Perceptive Advisors6 funds on PPLI.comUSD 39m0.6%
3POINT72 Asset Management17 funds on PPLI.comUSD 29m0.0%
4Baker Bros. Advisors2 funds on PPLI.comUSD 19m0.1%
5Two Sigma Investments35 funds on PPLI.comUSD 15m0.0%
6Eversept Partners3 funds on PPLI.comUSD 13m0.7%
7Citadel Advisors32 funds on PPLI.comUSD 12m0.0%
8Marshall Wace LLP84 funds on PPLI.comUSD 11m0.0%
9Millennium Management6 funds on PPLI.comUSD 6.3m0.0%
10Tudor Investment Corporation10 funds on PPLI.comUSD 5.2m0.0%
11Sphera Funds Management1 fund on PPLI.comUSD 3.3m0.4%
12Ally Bridge Group (Ny)3 funds on PPLI.comUSD 2.9m2.6%
13Exome Asset Management2 funds on PPLI.comUSD 1.7m1.1%
14Dafna Capital Management6 funds on PPLI.comUSD 1.6m0.3%
15LMR Partners2 funds on PPLI.comUSD 1m0.0%
16Verdad Advisers6 funds on PPLI.comUSD 662,0000.6%
17HighVista Strategies27 funds on PPLI.comUSD 637,0000.1%
18Awm Investment Company6 funds on PPLI.comUSD 562,0000.0%
19Walleye Capital8 funds on PPLI.comUSD 474,0000.0%
20Squarepoint Ops7 funds on PPLI.comUSD 421,0000.0%
21Landscape Capital Management4 funds on PPLI.comUSD 353,0000.0%
22Engineers Gate Manager1 fund on PPLI.comUSD 312,0000.0%
23683 Capital Management2 funds on PPLI.comUSD 75,0000.0%
24Freestone Grove Partners1 fund on PPLI.comUSD 71,1450.0%
25Boothbay Fund Management2 funds on PPLI.comUSD 56,2500.0%
26Nierenberg Investment Management Company3 funds on PPLI.comUSD 47,0810.0%
27The Quarry1 fund on PPLI.comUSD 7760.0%
Next: where it matters most
Where it matters most

For Kynam Capital Management it is 4.5% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1Kynam Capital ManagementUSD 81m4.5%
2Ally Bridge Group (Ny)USD 2.9m2.6%
3Exome Asset ManagementUSD 1.7m1.1%
4Eversept PartnersUSD 13m0.7%
5Verdad AdvisersUSD 662,0000.6%
6Perceptive AdvisorsUSD 39m0.6%
7Sphera Funds ManagementUSD 3.3m0.4%
8Dafna Capital ManagementUSD 1.6m0.3%
9HighVista StrategiesUSD 637,0000.1%
10Baker Bros. AdvisorsUSD 19m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds CytomX Therapeutics, Inc.

What is the ticker symbol of CytomX Therapeutics, Inc.?

CytomX Therapeutics, Inc. trades under the symbol CTMX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 23284F105.

Which hedge funds own CytomX Therapeutics, Inc. (Nasdaq: CTMX)?

27 of the 720 hedge fund managers PPLI.com tracks reported CytomX Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by Kynam Capital Management (USD 81m), Perceptive Advisors (USD 39m), POINT72 Asset Management (USD 29m), Baker Bros. Advisors (USD 19m) and Two Sigma Investments (USD 15m).

How many hedge funds hold CytomX Therapeutics, Inc.?

27 managers in our coverage reported it, and between them they run 278 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on CytomX Therapeutics, Inc.?

Kynam Capital Management, where the position was 4.5% of the reported 13F book at 30 June 2026.

Does this show who is short CytomX Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with CytomX Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.